Centers | ||
|
|
|
EU-OPENSCREEN | Drug Discovery Unit | Chemical Genomics Facility at Purdue Institute for Drug Discovery |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
The Drug Discovery Unit (DDU) is a fully integrated drug discovery group established to translate world-class biology research into novel drug targets and candidate drugs. Housed within purpose built facilities at the University of Dundee, the DDU... Read more |
The Chemical Genomics Facility is a core facility at Purdue Institute for Drug Discovery that provides expertise and resources needed in the early stage of drug discovery. The services include small molecule libraries, access to automated equipment... Read more |
Partnerships |
Events |
Jobs |
Sanford-Burnham Partners with Johnson and Johnson to Identify New Treatments for Neurological DisordersSanford-Burnham Medical Institute and Janssen a unit of Johnson and Johnson have entered into research and development partnership to identify novel targets and develop drugs to treat Alzheimer's disease and psychiatric disorders. This multi year... View all Sanofi and Weill Cornell Medical College to Discover New Drus to Treat TuberculosisSanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment of tuberculosis and increase effectiveness of... View all Johnson & Johnson to Support Pain Research at Queensland UniversityJohnson & Johnson and Institute for Molecular Bioscience (IMB) at University of Queensland have entered into research agreement to develop peptides using IMB's novel assay to treat chronic pain. Johnson & Johnson and its affiliates will provide... View all |
No EVENTS for listing |
No Job Posts |
